Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
|
Jul 31, 2018 |
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
|
May 04, 2018 |
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
|
Jan 07, 2018 |
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
|
Jan 05, 2018 |
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
|
Jan 04, 2018 |
Pinpointing the Top Questions about Biosimilars in Rheumatology
|
Nov 30, 2017 |
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
|
Oct 29, 2017 |
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
|
Aug 17, 2017 |
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
|
Jul 28, 2017 |
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
|
Jul 25, 2017 |
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
|
May 30, 2017 |
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
|
May 22, 2017 |
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
|
May 18, 2017 |
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
|
May 17, 2017 |
Introducing FDA's Drug Information Soundcast in Clinical Oncology (DISCO)
|
May 16, 2017 |
FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin
|
May 16, 2017 |
FDA Restricts Use of Prescription Codeine and Tramadol Pain Medicines in Children
|
Apr 20, 2017 |
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)
|
Feb 23, 2010 |
FDA: Product Confusion with Maalox Total Relief and Maalox Liquid Products
|
Feb 18, 2010 |
FDA: Advisory on Body Building Products
|
Jun 17, 2009 |